94-9074. National Cancer Institute; Meeting of the Cancer Clinical Investigation Review Committee  

  • [Federal Register Volume 59, Number 73 (Friday, April 15, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-9074]
    
    
    [[Page Unknown]]
    
    [Federal Register: April 15, 1994]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
    National Institutes of Health
    
     
    
    National Cancer Institute; Meeting of the Cancer Clinical 
    Investigation Review Committee
    
        Pursuant to Public Law 92-463, notice is hereby given of the 
    meeting of the Cancer Clinical Investigation Review Committee, National 
    Cancer Institute, on May 16, 1994, The Hyatt Regency Dallas, 300 
    Reunion Boulevard, Dallas, Texas 75207.
        This meeting will be open to the public on May 16, from 6:30 p.m. 
    to 7 p.m., to review administrative details and other cancer clinical 
    investigation review issues. Attendance by the public will be limited 
    to space available.
        In accordance with the provisions set forth in sections 552b(c)(4) 
    and 552(c)(6), title 5, U.S.C. and section 10(d) of Public Law 92-463, 
    the meeting will be closed to the public on May 16, from approximately 
    7 p.m. to adjournment for the review, discussion and evaluation of 
    individual grant applications. These applications and the discussions 
    could reveal confidential trade secrets or commercial property such as 
    patentable material, and personal information concerning individuals 
    associated with the applications, the disclosure of which would 
    constitute a clearly unwarranted invasion of personal privacy.
        Ms. Carole Frank, the Committee Management Officer, National Cancer 
    Institute, Executive Plaza North, room 630, National Institutes of 
    Health, Bethesda, Maryland 20892 (301-496-5708) will provide a summary 
    of the meeting and the roster of committee members, upon request.
        Dr. John W. Abrell, Scientific Review Administrator, Cancer 
    Clinical Investigation Review Committee, National Cancer Institute, 
    Executive Plaza North, room 635B, National Institutes of Health, 
    Bethesda, Maryland 20892 (301-496-9767) will furnish substantive 
    program information.
        Individuals who plan to attend and need special assistance, such as 
    sign language interpretation or other reasonable accommodations, should 
    contact Dr. John W. Abrell, (301) 496-9767 in advance of the meeting.
    
    
    (Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
    Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
    Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
    Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
    Cancer Research Manpower; 93.399, Cancer Control.)
    
        Dated: April 11, 1994.
    Susan K. Feldman,
    Committee Management Officer, NIH.
    [FR Doc. 94-9074 Filed 4-14-94; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Published:
04/15/1994
Department:
National Institutes of Health
Entry Type:
Uncategorized Document
Document Number:
94-9074
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: April 15, 1994